Loading clinical trials...
Loading clinical trials...
Phase 4, Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults in the Out-patient Setting: Prospective, Multicenter, Double-blind, Placebo-controlled Randomized Parallel-arm Clinical Study
Conditions
Interventions
Sinquanon
Placebo
Locations
3
Bulgaria
University Hospital "St George"
Plovdiv, Bulgaria
University Hospital for Pulmonary Diseases " St. Sofia"
Sofia, Bulgaria
University Hospital "Tsaritsa Yoanna - ISUL"
Sofia, Bulgaria
Start Date
November 27, 2022
Primary Completion Date
March 20, 2023
Completion Date
April 25, 2023
Last Updated
October 21, 2024
NCT07234448
NCT03181516
NCT06665503
NCT04212403
NCT00182429
NCT02993419
Lead Sponsor
Neopharm Bulgaria Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions